![](https://investorshub.advfn.com/uicon/639708.png?cb=1519418134)
Monday, December 11, 2017 4:08:47 PM
when you are a publicly traded company your responsibility is to the shareholders and major changes are voted on by the board. company purchase decisions are run by bean counters looking to increase bottom line profit and ER numbers. no one on the board would approve spending even 10m on updating their robotic tech because of the monopoly. its not like a hospital is going to buy anyone else's lapro bot, newer or not.
Your view of the FDA clearance info is completely wrong.
FDA reports as follows: "FDA concluded that these study data, supported by real-world evidence, along with performance testing under simulated use and worst-case scenario conditions, demonstrated the substantial equivalence of the Senhance System to the da Vinci Si IS3000 device for gynecological and colorectal procedures."
Laymen terms "equally effective" = "substantial equivalence", syn.
e.g. : "substantial" and "equivalent" - google definition of those words. are you sure you know what "equivalent" means?
FDA demonstrated that the Senhance device is substantially equivalent to a legally marketed predicate device (DaVinci).
FDA granted clearance of the Senhance System to TransEnterix Surgical Inc.
If FDA test had only shown Senhance to be "similar" as you claim, it would have failed.
JMO, it's not cool to offer false facts in a stock message forum.
here is the FDA report: https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm580452.htm
Recent ASXC News
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 07/31/2024 10:50:20 AM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 07/30/2024 10:50:10 AM
- Independent Proxy Advisory Firm ISS Recommends Asensus Surgical Stockholders Vote “FOR” the Pending Merger with KARL STORZ • GlobeNewswire Inc. • 07/30/2024 10:45:00 AM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 07/29/2024 10:52:07 AM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 07/29/2024 10:50:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/29/2024 10:50:18 AM
- Glass Lewis Recommends Asensus Surgical Stockholders Vote “FOR” Proposals Relating to Proposed Merger with KARL STORZ • GlobeNewswire Inc. • 07/29/2024 10:45:57 AM
- Asensus Surgical Announces The Rocky Mountain Hospital for Children in Denver, Colorado to Initiate Senhance Surgery Program • GlobeNewswire Inc. • 07/24/2024 10:50:34 AM
- Asensus Surgical Receives FDA 510(k) Clearance for Senhance Surgical System in Urology • GlobeNewswire Inc. • 07/23/2024 10:50:00 AM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 07/17/2024 08:31:21 PM
- Asensus Surgical Announces LKH-Universitätsklinikum Graz Hospital in Austria to Initiate Senhance Surgery Program • GlobeNewswire Inc. • 07/16/2024 10:50:00 AM
- Form SC 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 07/15/2024 09:33:42 PM
- Asensus Surgical Announces St. Marianna University School of Medicine Yokohama City Seibu Hospital in Japan to Initiate Senhance Surgery Program • GlobeNewswire Inc. • 06/24/2024 10:55:00 AM
- Kuehn Law Encourages ICCH, DO, ASXC, and DPSI Investors to Contact Law Firm • PR Newswire (US) • 06/11/2024 12:04:00 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 06/07/2024 08:19:53 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 06/07/2024 12:50:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/07/2024 12:50:23 PM
- Asensus Surgical Announces Signing of Definitive Merger Agreement with KARL STORZ • GlobeNewswire Inc. • 06/07/2024 12:45:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/15/2024 08:33:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/15/2024 10:55:34 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/14/2024 08:51:25 PM
- Asensus Surgical, Inc. Reports Operating and Financial Results for the First Quarter 2024 • GlobeNewswire Inc. • 05/14/2024 08:05:00 PM
- Asensus Surgical, Inc. Schedules First Quarter Financial and Operating Results Conference Call for May 14, 2024 • GlobeNewswire Inc. • 05/07/2024 10:55:00 AM
- Asensus Surgical Announces Sendai Tokushukai Hospital in Japan to Initiate Senhance Surgery Program • GlobeNewswire Inc. • 04/29/2024 10:55:00 AM
- Asensus Surgical, Inc. Announces Non-Binding Acquisition Proposal and Exclusivity Arrangement with KARL STORZ SE & Co. KG • GlobeNewswire Inc. • 04/03/2024 12:45:00 PM
Kona Gold Beverages, Inc. Announces Strategic Initiatives and Corporate Direction Changes • KGKG • Aug 2, 2024 2:00 PM
POET and Luxshare Tech Expand Product Offerings for Artificial Intelligence Networks • POET • Aug 1, 2024 9:28 AM
Management Discusses Financial Filings of Global Arena Holding Inc., for 10-K 2023 and 10-Q, 1st Quarter 2024 • GAHC • Aug 1, 2024 9:14 AM
VAYK Announces LOI to Acquire $1 Million Home Service Company to Support Airbnb Business • VAYK • Aug 1, 2024 9:00 AM
Duane Forrester Joins INDEXR as SVP of Search • MONI • Jul 31, 2024 11:46 AM
Lingerie Fighting Championships Help Fulfill Death-Bed Promise With First Major Motion Picture • BOTY • Jul 31, 2024 9:00 AM